Asclemed Lidolog Kit Recall: FDA Class III

Why it was recalled

Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan

Product description

Lidolog Kit, Kit Contains: Lidocaine HCl Injection, USP, 2% (2mL) vial, 1 Dose, Single use Only, Rx Only, Distributed by: Enovachem Pharmaceuticals, Torrance, CA 90501, NDC: 76420-760-01.

Lot numbers, UPCs & expiration codes

Lot: 070126X1, Exp. 12/31/2027.

Where it was sold

Within U.S. - Tennessee

What to do if you have this product

Compare the lot number and expiration date on your package with the codes above.
Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
If you have symptoms you think are related, contact your doctor. In an emergency call 911.
Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number: D-0713-2026
Classification: Class III
Status: Ongoing
Recall initiated: Jul 15, 2026
FDA report date: Jul 29, 2026
Quantity: 18 kits
Recall type: Voluntary: Firm initiated
Recalling firm: Asclemed USA Inc.

Original FDA data

Every field from FDA enforcement report D-0713-2026, exactly as published.

Show all FDA fields

City: Torrance
State: CA
Status: Ongoing
Country: United States
Event ID: 99408
Address: 379 Van Ness Ave Ste 1403
Code information: Lot: 070126X1, Exp. 12/31/2027.
Postal code: 90501-7211
Report date: Jul 29, 2026
Product type: Drugs
Recall number: D-0713-2026
Classification: Class III
Recalling firm: Asclemed USA Inc.
Product quantity: 18 kits
Reason for recall: Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan
Voluntary / mandated: Voluntary: Firm initiated
Product description: Lidolog Kit, Kit Contains: Lidocaine HCl Injection, USP, 2% (2mL) vial, 1 Dose, Single use Only, Rx Only, Distributed by: Enovachem Pharmaceuticals, Torrance, CA 90501, NDC: 76420-760-01.
Distribution pattern: Within U.S. - Tennessee
Recall initiation date: Jul 15, 2026
Initial firm notification: E-Mail
Center classification date: Jul 20, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0713-2026, published Jul 29, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: Oct 8, 2026. Content last changed: Oct 6, 2026.

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

Asclemed Lidolog Kit Recall

Summary